Publications by authors named "Torben Palshof"

Claim this Profile
T
Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trial.
Maj-Britt Jensen, Jens Fabricius Krarup, Torben Palshof, Henning T Mouridsen, Bent Ejlertsen

Acta Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry.
Erik Jakobsen, Anders Green, Kell Oesterlind, Torben Riis Rasmussen, Maria Iachina, Torben Palshof

J Thorac Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Danish Lung Cancer Registry].
Erik Jakobsen, Anders Green, Kell Østerlind, Torben Palshof

Ugeskr Laeger· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring renal function during chemotherapy.
Louise B Hartlev, Charlotte R Boeje, Henrik Bluhme, Torben Palshof, Michael Rehling

Eur J Nucl Med Mol Imaging· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The course of cancer in health care--time for a time out?].
Niels Kroman, Torben Palshof

Ugeskr Laeger· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review].
Lise Pedersen, Torben Palshof

Ugeskr Laeger· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National quality measurement using clinical indicators: the Danish National Indicator Project.
Jan Mainz, Anne-Marie Hansen, Torben Palshof, Paul D Bartels

J Surg Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[...and the winner is...].
Torben Palshof

Ugeskr Laeger· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results.
Erik Jakobsen, Torben Palshof, Kell Osterlind, Hans Pilegaard

Eur J Cardiothorac Surg· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Monitoring renal function in patients treated with cytostatics].
Louise Brøndt Hartlev, Charlotte Bøje Rotbøl, Henrik Bluhme, Torben Palshof, Michael Rehling

Ugeskr Laeger· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Morten Sorensen, Ulrik Lassen, Torben Palshof, Britta Bjerregaard Jensen, Jørgen Johansen

Lung Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delay in diagnosis of lung cancer in general practice.
Marianne Bjerager, Torben Palshof, Ronald Dahl, Peter Vedsted, Frede Olesen

Br J Gen Pract· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of HRCT and Tc-depreotide in the evaluation of pulmonary lesions.
Karin Rasmussen, Hans H Madsen, Finn Rasmussen, Torben R Rasmussen, Ulrik Baandrup, Torben Palshof

J Thorac Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[General practitioners' attitudes towards the diagnosis of lung cancer and the diagnostic organisation].
Marianne Bjerager, Torben Palshof, Ronald Dahl, Frede Olesen

Ugeskr Laeger· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Quality assurance and clinical databases].
Torben Palshof, Erik Jakobsen, Kell Østerlind

Ugeskr Laeger· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood accessory cells modulate committed colony-forming units but not 5-week cobblestone-area-forming cell outgrowth from CD34+ cells.
Gitte Olesen, Hanne Tønder, Torben Palshof, Peter Hokland

Eur J Haematol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Palliative medicine education].
Lise Pedersen, Anders Bonde Jensen, Bent Enig, Peter Vejby Hansen, Jørn Herrstedt, Torben Palshof

Ugeskr Laeger· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis